Inclisiran in Cardiovascular Health: A Review of Mechanisms, Efficacy, and Future Prospects
Medical Science Monitor · 27.02.2025 · 31
DOI: 10.12659/msm.946439 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Science Monitor, online erschienen am 27.02.2025. Verfasst von Fanke Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Renhe Hospital Affiliated to Three Gorges University, Yichang, Hubei, China. Hauptthemen laut MEDLINE: Cardiovascular Diseases, RNA, Small Interfering. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Renhe Hospital Affiliated to Three Gorges University, Yichang, Hubei, China.
Zitieren
APA
Huang, F., Dai, Q., Zhou, Y., Guan, J., Wu, J., Dong, Y., & Lv, J. (2025). Inclisiran in Cardiovascular Health: A Review of Mechanisms, Efficacy, and Future Prospects. Medical Science Monitor, 31. https://doi.org/10.12659/msm.946439
Vancouver
Huang F, Dai Q, Zhou Y, Guan J, Wu J, Dong Y, et al. Inclisiran in Cardiovascular Health: A Review of Mechanisms, Efficacy, and Future Prospects. Medical Science Monitor. 2025;31. doi:10.12659/msm.946439
BibTeX
@article{Huang2025,
author = {Huang, Fanke and Dai, Qiuting and Zhou, Yilu and Guan, Jing and Wu, Jingjing and Dong, Yanyan and Lv, Jianfeng},
title = {Inclisiran in Cardiovascular Health: A Review of Mechanisms, Efficacy, and Future Prospects},
journal = {Medical Science Monitor},
year = {2025},
volume = {31},
doi = {10.12659/msm.946439}
}
EUVIMED